Its solid-state batteries are already showing promise with real-world tests delivering over 745 miles of range on a single charge. Now, Factorial Energy is going public as it aims to bring the ...

Abstract: Despite the increasing interest in sequential transfer optimization (STO), a comprehensive benchmark suite for systematically comparing various STO algorithms remains underexplored. Existing ...

J. Bullivant personal power generator test demonstrates energy solutions. Woman checks Bernese mountain dog's fur, sees something moving with a tail After winning his first Oscar, Tom Cruise kept ...

A plan to kill the exit exam New Jersey high school students must take to graduate is once again being debated by state lawmakers. The state Assembly voted Monday to eliminate the high school exit ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. Abbott said Thursday it would buy Exact Sciences, the maker of tests ...

Nov 19 (Reuters) - Medical device maker Abbott Laboratories (ABT.N), opens new tab is nearing a potential takeover of cancer test maker Exact Sciences Corp (EXAS.O), opens new tab, Bloomberg News ...

Abbott Laboratories is nearing a potential acquisition of cancer screening company Exact Sciences Corp., people familiar with the matter said, in what could be the biggest deal of the year in the ...

Molecular diagnostics firm BillionToOne raised $314 million in the DNA test maker’s upsized initial public offering but saw share values slide after the first day of trading. The Menlo Park, ...